NCT06074458Active, not recruiting
GO TEAM: Glucose Optimization Through Technology Assisted Management
GO TEAM INTERVENTION PROTOCOL: GLUCOSE OPTIMIZATION THROUGH TECHNOLOGY ASSISTED MANAGEMENT: Use of a Diabetes Dashboard and Community Health Worker to Decrease Disparities in Technology Use in Pediatric T1D
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
Black/African American children and young adults with type 1 diabetes are less likely to use diabetes technologies, such as continuous glucose monitors, insulin pumps, and automated insulin delivery systems, compared to White children and young adults. The investigators are working to find ways to make sure that all patients with type 1 diabetes are equally able to use these technologies. The purpose of this study is to find out if a new computer program for the diabetes team, along with a smartphone app (called Glucosano) for patients/parents, as well as a community health worker, are accepted and used by Black/African American patients and parents living with type 1 diabetes, and if this can help decrease racial disparities in the use of diabetes technologies.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 3 Oct 2023
- Start date
- 29 Jan 2024
- Primary completion date
- 27 Jan 2027
- Lead sponsor
- Sarah MacLeish
- Diseases
- Type 1 diabetes
- NCT number
- NCT06074458
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 29 Jan 2024 to the primary completion date, 27 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinical diagnosis of Type 2 or monogenic diabetes
Other
- Completed high school
- Non-English speaking guardians
- Automated insulin delivery system use within the past 3 months
- Custody of children and family services
Who the study is looking for
- Self-reported as Non-Hispanic Black
- Clinical diagnosis of T1D requiring treatment with insulin at the time of consent
- Not currently (within the past 3 months) using an automated insulin delivery system \\
- Willingness to wear a continuous glucose monitor for 10 days at 3 different time points, and willingness to consider use of a personal continuous glucose monitor
Age in the registry: 8 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals Cleveland Medical Center* Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.